Medicine and Dentistry
Cancer Cell
100%
Breast Cancer
100%
Cell Proliferation
100%
Cell Cycle
100%
Adenosine Phosphate
100%
Protein Kinases
100%
Glycon
100%
MCF-7
50%
Estrogen Receptor
50%
Acetyl-CoA
37%
Carboxylase
37%
Estrogen Receptor Negative Breast Cancer
37%
Breast Cancer Cell Line
25%
Protein P53
25%
In Vitro
12%
Cell Line
12%
Immunoblotting
12%
Cyclic AMP Dependent Protein Kinase
12%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
12%
Antiproliferative Activity
12%
Fatty Acid Synthesis
12%
G1 Phase
12%
Fluorescence Activated Cell Sorting
12%
G1/S Transition
12%
Growth Inhibitor
12%
Tetrazole Derivative
12%
Keyphrases
Metformin
100%
Adenosine Monophosphate-activated Protein Kinase Pathway
100%
Breast Cancer Cell Proliferation
100%
Phosphorylation
57%
Estrogen Receptor-positive
57%
Adenosine Monophosphate-activated Protein Kinase
57%
Acetyl-CoA Carboxylase
42%
Estrogen Receptor-positive Breast Cancer
42%
MCF-7
28%
A-769662
28%
Concentration-dependent
28%
Breast Cancer Cell Lines
28%
MCF-7 Cells
28%
Raptor
28%
Cell Proliferation
14%
MDA-MB-231
14%
Fluorescence-activated Cell Sorting
14%
Kinase Activation
14%
Mechanism of Action
14%
Downstream Targets
14%
G1 Phase
14%
P70S6K
14%
Antiproliferative Activity
14%
Breast Cancer Cells
14%
Immunoblotting
14%
Suppression Effect
14%
Metformin Treatment
14%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
14%
MDA-MB-231 Cells
14%
Fatty Acid Synthesis
14%
Tetrazole
14%
G1 Cell Cycle Arrest
14%
Growth Inhibitor
14%
Immunology and Microbiology
Cancer Cell
100%
Cell Proliferation
100%
P53
100%
Cell Cycle
100%
Breast Cancer Cell Line
100%
Cell Cycle G1 Phase
50%
Cell Line
50%
Fluorescence Activated Cell Sorting
50%
Western Blot
50%
Fatty Acid Synthesis
50%
G1 Phase Cell Cycle Checkpoint
50%
Antiproliferative Activity
50%
Growth Inhibitor
50%
Kinase A
50%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cell Proliferation
100%
Cell Cycle
100%
Protein Kinases
100%
Adenosine Monophosphate
100%
Estrogen Receptor
100%
Acetyl-CoA Carboxylase
42%
P53
28%
Protein Kinase A
14%
G1 Phase
14%
Antiproliferative Activity
14%
G1/S Transition
14%
Fatty Acid Synthesis
14%
Flow Cytometry
14%
Immunoblotting
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Adenosine Phosphate
100%
Protein Kinases
100%
Metformin
100%
Estrogen Receptor
50%
Carboxylase
37%
Acetyl-CoA
37%
Estrogen Receptor Negative Breast Cancer
37%
Protein P53
25%
Cyclic AMP Dependent Protein Kinase
12%
Western Blot
12%
Fatty Acid
12%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
12%
Fluorescence Activated Cell Sorting
12%
Growth Inhibitor
12%
Tetrazole Derivative
12%